# Tonix Pharmaceuticals Holding Corp.: filings

TNXP · Nasdaq · CIK 1430306 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tnxp.md) · [Financials](/companies/tnxp/financials.md) · [Filings](/companies/tnxp/filings.md) · [Insiders](/companies/tnxp/insiders.md)

## Reports and events: 833 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 691, 4 329, 10-Q 53, 424B5 47, SC 13G/A 40, CORRESP 39, 3 28, SC 13G 28, UPLOAD 26, DEF 14A 23, EFFECT 21, S-1/A 20, 10-K 18, PRE 14A 14, 5 13, S-8 12, 8-K/A 10, S-1 10, S-3 10, FWP 8, 424B3 7, SCHEDULE 13G/A 6, 10-K/A 5, 424B4 5, 4/A 5, D 5, SCHEDULE 13G 5, ARS 4, DEFA14A 4, S-3/A 3, POS AM 2, SC 13D/A 2, SEC STAFF LETTER 2, 8-A12B 1, 8-A12G 1, AW 1, CERTNAS 1, CT ORDER 1, D/A 1, NT 10-K 1, NT 10-Q 1, POS EX 1, RW 1, S-3MEF 1, SC 13D 1, SC 14F1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 11:00 ET | [8-K](/filings/0001493152-26-047139.md) | 2.02 Results of operations; 8.01 Other events | 0001493152-26-047139 |
| 2026-10-02 | 21:20 ET | [8-K](/filings/0001493152-26-045603.md) | 8.01 Other events | 0001493152-26-045603 |
| 2026-09-22 | 11:05 ET | [8-K](/filings/0001493152-26-043644.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-043644 |
| 2026-09-08 | 11:05 ET | [8-K](/filings/0001493152-26-041689.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041689 |
| 2026-08-18 | 20:00 ET | [8-K](/filings/0001493152-26-039000.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001493152-26-039000 |
| 2026-08-10 | 12:09 ET | [10-Q](/filings/0001999371-26-017452.md) | Quarterly report, period 2026-06-30 | 0001999371-26-017452 |
| 2026-08-10 | 11:15 ET | [8-K](/filings/0001493152-26-036740.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036740 |
| 2026-08-03 | 11:05 ET | [8-K](/filings/0001493152-26-035741.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-035741 |
| 2026-07-21 | 20:05 ET | [8-K](/filings/0001493152-26-034079.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-034079 |
| 2026-07-13 | 11:05 ET | [8-K](/filings/0001493152-26-032925.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032925 |
| 2026-06-29 | 11:05 ET | [8-K](/filings/0001493152-26-030408.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-030408 |
| 2026-06-08 | 11:05 ET | [8-K](/filings/0001493152-26-027621.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-027621 |
| 2026-05-27 | 11:05 ET | [8-K](/filings/0001493152-26-025324.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-025324 |
| 2026-05-15 | 13:25 ET | [8-K](/filings/0001999371-26-010790.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-010790 |
| 2026-05-11 | 21:17 ET | [8-K](/filings/0001999371-26-010487.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001999371-26-010487 |
| 2026-05-11 | 21:15 ET | [10-Q](/filings/0001999371-26-010486.md) | Quarterly report, period 2026-03-31 | 0001999371-26-010486 |
| 2026-05-07 | 21:20 ET | [8-K](/filings/0001999371-26-010226.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001999371-26-010226 |
| 2026-05-06 | 11:05 ET | [8-K](/filings/0001999371-26-010039.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-010039 |
| 2026-05-01 | 20:57 ET | [8-K](/filings/0001999371-26-009744.md) | 2.02 Results of operations; 8.01 Other events | 0001999371-26-009744 |
| 2026-04-29 | 11:05 ET | [8-K](/filings/0001999371-26-009289.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-009289 |
| 2026-04-23 | 11:11 ET | [8-K](/filings/0001999371-26-008771.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-008771 |
| 2026-03-31 | 11:05 ET | [8-K](/filings/0001999371-26-007254.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-007254 |
| 2026-03-30 | 12:00 ET | [DEF 14A](/filings/0001999371-26-007108.md) | Proxy statement, period 2026-05-07 | 0001999371-26-007108 |
| 2026-03-26 | 11:00 ET | [8-K](/filings/0001999371-26-006915.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-006915 |
| 2026-03-18 | 10:01 ET | [8-K](/filings/0001999371-26-006169.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001999371-26-006169 |
| 2026-03-13 | 10:01 ET | [8-K](/filings/0001999371-26-005742.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001999371-26-005742 |
| 2026-03-12 | 21:29 ET | [10-K](/filings/0001999371-26-005730.md) | Annual report, period 2025-12-31 | 0001999371-26-005730 |
| 2026-03-10 | 12:05 ET | [8-K](/filings/0001999371-26-005466.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-005466 |
| 2026-03-03 | 11:05 ET | [8-K](/filings/0001999371-26-004897.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-26-004897 |
| 2026-02-03 | 12:00 ET | [8-K](/filings/0001999371-26-002429.md) | 2.02 Results of operations; 8.01 Other events | 0001999371-26-002429 |
| 2025-12-29 | 21:44 ET | [8-K](/filings/0001999371-25-021283.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-021283 |
| 2025-12-29 | 12:45 ET | [8-K](/filings/0001999371-25-021194.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-021194 |
| 2025-12-16 | 12:05 ET | [8-K](/filings/0001999371-25-020361.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-020361 |
| 2025-12-09 | 12:33 ET | [8-K](/filings/0001999371-25-019833.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-019833 |
| 2025-11-24 | 12:06 ET | [8-K](/filings/0001999371-25-018430.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001999371-25-018430 |
| 2025-11-21 | 21:48 ET | [8-K](/filings/0001999371-25-018392.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-018392 |
| 2025-11-18 | 22:21 ET | [8-K](/filings/0001999371-25-018108.md) | 8.01 Other events | 0001999371-25-018108 |
| 2025-11-17 | 12:05 ET | [8-K](/filings/0001999371-25-017964.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-017964 |
| 2025-11-10 | 21:30 ET | [10-Q](/filings/0001999371-25-017370.md) | Quarterly report, period 2025-09-30 | 0001999371-25-017370 |
| 2025-11-10 | 21:26 ET | [8-K](/filings/0001999371-25-017369.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001999371-25-017369 |
| 2025-10-27 | 11:00 ET | [8-K](/filings/0001999371-25-016108.md) | 2.02 Results of operations; 8.01 Other events | 0001999371-25-016108 |
| 2025-10-22 | 11:05 ET | [8-K](/filings/0001999371-25-015796.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-015796 |
| 2025-10-07 | 12:30 ET | [8-K](/filings/0001999371-25-014776.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-014776 |
| 2025-09-30 | 12:36 ET | [8-K](/filings/0001999371-25-014216.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-014216 |
| 2025-09-29 | 12:24 ET | [8-K](/filings/0001999371-25-014108.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-014108 |
| 2025-09-18 | 12:05 ET | [8-K](/filings/0001999371-25-013498.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-013498 |
| 2025-09-17 | 11:05 ET | [8-K](/filings/0001999371-25-013413.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-013413 |
| 2025-08-18 | 11:01 ET | [8-K](/filings/0001999371-25-011510.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-011510 |
| 2025-08-15 | 21:23 ET | [8-K](/filings/0001999371-25-011478.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-011478 |
| 2025-08-11 | 20:49 ET | [8-K](/filings/0001999371-25-011053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001999371-25-011053 |

Page 1 of 17. [Older](/companies/tnxp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.